Hologic has earned extended CE Mark approval for its LOCalizer radiofrequency identification (RFID) tag for long-term placement in breast lesions.

The non-radioactive guidance system’s expanded CE Mark means that the tag can now be placed in patients more than 30 days before breast-conserving surgery.

The device is used to accurately mark and target breast lesions during surgery and eliminates the need to place a wire before beginning the procedure.